RE:RE:Pristine Surgical FDA report
damn you have a very myopic vision of people trying to build a strong and lasting company vs those that will surely face huge problems. You can take all the necessary time to build solid foundations and do intensive capital raise prior to going public or you can do things quick fly by the seam of your pants and hope there is large hype that keeps your share values up to do raises later in which start ups fail miserably. In the pharmaceutical it is hugely capital intensive and Pristine is making the right moves it is building a business by what I see to last I will add not fly by the night company that will fold like a cheap deck of cards. I would rather companies take the proper time like this make sure they are solid then list vs those who do a half a$$ job and find themselves in dilution problems at low values killing the share price and constantly needing to consolidate to get anything impacted done. Way better Pristine is dotting the I and crossing ts than get into the huge dilution game to consolidate. That is the impression they are leaving me with but of course we will not fully know how things exactly work out until it does trade however you build long lasting strong foundations chances are you have a startup which if not on the main exchange already will likely get their within 3 years. In any case that is my 2 cents. Time will tell all things during which it all comes down to strategically managing one's shares. I blame myself for my losses as much as I take credit for the gains. Anyways either nxo gets the job done this year or it doesn't I have said what I have and I stand strongly behind it. $2 to $5 plus this year!!!